IBM reported solid Q1 numbers as the company continues a transformation to analytics, cloud and mobile.
The market focuses too much on toppling numbers, missing the huge cash flow benefits to shareholders.
Ignore the skeptics and use any dips caused by the tax benefits as an opportunity to buy a stock with a high yield in the middle of a transformation.
The skeptics keep telling investors to ignore the results at IBM (NYSE:IBM) as the company is dying a slow death. Barclays even slapped a $125 target on the stock prior to earnings, suggesting the recent rally would dissipate on weak revenues.